Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess

Aim: This study aimed to evaluate the utility of the combined use of contrast-enhanced ultrasound (CEUS) and intracavitary CEUS (IC-CEUS) with diluted SonoVue in the management of percutaneous treatment for pyogenic liver abscess (PLA). Methods: 36 patients (23 males, 13 females; mean age 64 ± 13.9...

Full description

Saved in:
Bibliographic Details
Main Author: Giampiero Francica
Format: Article
Language:English
Published: Open Exploration 2024-09-01
Series:Exploration of Drug Science
Subjects:
Online Access:https://www.explorationpub.com/uploads/Article/A100861/100861.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1825199566589263872
author Giampiero Francica
author_facet Giampiero Francica
author_sort Giampiero Francica
collection DOAJ
description Aim: This study aimed to evaluate the utility of the combined use of contrast-enhanced ultrasound (CEUS) and intracavitary CEUS (IC-CEUS) with diluted SonoVue in the management of percutaneous treatment for pyogenic liver abscess (PLA). Methods: 36 patients (23 males, 13 females; mean age 64 ± 13.9 years) with 39 PLAs (mean size 7.6 ± 3.4 cm) were selected for percutaneous catheter drainage (PCD) and/or percutaneous needle aspiration (PNA). CEUS and IC-CEUS were employed during the interventional maneuver and follow-up during hospital stay in all cases. Results: 33 patients with 24 PLAs underwent PCD, 8 patients with 10 PLAs were treated with single or multiple PNA, and the combination of PCD and PNA was used in the remaining 5 cases. During the treatment planning phase, the combined use of CEUS and IC-CEUS affected therapeutic choices (e.g., drainage technique, additional therapeutic measures) in comparison with pre-operative imaging in 66.7% of patients. Throughout the follow-up period, CEUS and IC-CEUS facilitated monitoring of PLA evolution, providing crucial information, especially with IC-CEUS, on the optimal timing of catheter removal. No adverse events occurred after CEUS and IC-CEUS. Conclusions: The combination of CEUS and IC-CEUS proved to be a powerful and safe tool for tailoring US-guided percutaneous treatments to patients with PLA.
format Article
id doaj-art-4f07d35107a746a7b1d01b5d78c48f8a
institution Kabale University
issn 2836-7677
language English
publishDate 2024-09-01
publisher Open Exploration
record_format Article
series Exploration of Drug Science
spelling doaj-art-4f07d35107a746a7b1d01b5d78c48f8a2025-02-08T03:29:23ZengOpen ExplorationExploration of Drug Science2836-76772024-09-012555556610.37349/eds.2024.00061Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscessGiampiero Francica0https://orcid.org/0000-0002-9821-7966Interventional Ultrasound Unit, Pineta Grande Hospital, 81030 Castel Volturno, ItalyAim: This study aimed to evaluate the utility of the combined use of contrast-enhanced ultrasound (CEUS) and intracavitary CEUS (IC-CEUS) with diluted SonoVue in the management of percutaneous treatment for pyogenic liver abscess (PLA). Methods: 36 patients (23 males, 13 females; mean age 64 ± 13.9 years) with 39 PLAs (mean size 7.6 ± 3.4 cm) were selected for percutaneous catheter drainage (PCD) and/or percutaneous needle aspiration (PNA). CEUS and IC-CEUS were employed during the interventional maneuver and follow-up during hospital stay in all cases. Results: 33 patients with 24 PLAs underwent PCD, 8 patients with 10 PLAs were treated with single or multiple PNA, and the combination of PCD and PNA was used in the remaining 5 cases. During the treatment planning phase, the combined use of CEUS and IC-CEUS affected therapeutic choices (e.g., drainage technique, additional therapeutic measures) in comparison with pre-operative imaging in 66.7% of patients. Throughout the follow-up period, CEUS and IC-CEUS facilitated monitoring of PLA evolution, providing crucial information, especially with IC-CEUS, on the optimal timing of catheter removal. No adverse events occurred after CEUS and IC-CEUS. Conclusions: The combination of CEUS and IC-CEUS proved to be a powerful and safe tool for tailoring US-guided percutaneous treatments to patients with PLA.https://www.explorationpub.com/uploads/Article/A100861/100861.pdfcontrast-enhanced ultrasoundintracavitary contrast-enhanced ultrasoundliverabscesspercutaneous drainage
spellingShingle Giampiero Francica
Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
Exploration of Drug Science
contrast-enhanced ultrasound
intracavitary contrast-enhanced ultrasound
liver
abscess
percutaneous drainage
title Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
title_full Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
title_fullStr Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
title_full_unstemmed Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
title_short Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
title_sort clinical utility of combined contrast enhanced ultrasound and intracavitary contrast enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
topic contrast-enhanced ultrasound
intracavitary contrast-enhanced ultrasound
liver
abscess
percutaneous drainage
url https://www.explorationpub.com/uploads/Article/A100861/100861.pdf
work_keys_str_mv AT giampierofrancica clinicalutilityofcombinedcontrastenhancedultrasoundandintracavitarycontrastenhancedultrasoundinthepercutaneoustreatmentofpyogenicliverabscess